Publications by authors named "Ian Forgacs"

Claim this Profile
C
Conference report: improving outcomes for gastrointestinal cancer in the UK.
Ian Forgacs, Rachel Ashton, William Allum, Terry Bowley, Hilary Brown

Frontline Gastroenterol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficiencies in services for acute upper gastrointestinal bleeding.
Alan J Lobo, Simon M Greenfield, Ian Forgacs

BMJ· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of faecal occult blood tests in symptomatic patients.
Robert Steele, Ian Forgacs, Gwyn McCreanor, Sally Benton, Michael Machesney

BMJ· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of symptoms and expectations of advanced therapy for Parkinson's disease: preliminary report of a Patient-Reported Outcome tool for Advanced Parkinson's disease (PRO-APD).
Prashanth Reddy, Pablo Martinez-Martin, Richard G Brown, Kallol Ray Chaudhuri, Jean-Pierre Lin, Ian Forgacs

Health Qual Life Outcomes· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects.
Prashanth Reddy, Pablo Martinez-Martin, Alexandra Rizos, Anne Martin, Guy C Faye, Ian Forgacs

Clin Neuropharmacol· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
Holger Honig, Angelo Antonini, Pablo Martinez-Martin, Ian Forgacs, Guy C Faye

Mov Disord· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective white cell apheresis reduces relapse rates in patients with IBD at significant risk of clinical relapse.
Laurence Maiden, Ken Takeuchi, Rosie Baur, Ingi Bjarnason, John O'Donohue, Ian Forgacs

Inflamm Bowel Dis· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overprescribing proton pump inhibitors.
Ian Forgacs, Aathavan Loganayagam

BMJ· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal M2-pyruvate kinase (M2-PK): a novel marker of intestinal inflammation.
Guy Chung-Faye, Bu'hussain Hayee, Susan Maestranzi, Nora Donaldson, Ian Forgacs

Inflamm Bowel Dis· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychological approach to managing irritable bowel syndrome.
Bu'Hussain Hayee, Ian Forgacs

BMJ· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unexplained (non-cardiac) chest pain.
Mark Fox, Ian Forgacs

Clin Med (Lond)· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Private practice--definitely not a zero sum game.
Ian Forgacs

J R Soc Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastro-oesophageal reflux disease.
Mark Fox, Ian Forgacs

BMJ· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Death to all cliches.
Ian Forgacs

J R Soc Med· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal infection and irritable bowel syndrome.
Sally Parry, Ian Forgacs

Eur J Gastroenterol Hepatol· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Referee's half-time analysis.
Ian Forgacs

BMJ· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease.
Jeremy A Tibble, Gudmundur Sigthorsson, Russell Foster, Ian Forgacs, Ingvar Bjarnason

Gastroenterology· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis